↓ Skip to main content

Dove Medical Press

Article Metrics

A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report

Overview of attention for article published in Cancer Management and Research, March 2021
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report
Published in
Cancer Management and Research, March 2021
DOI 10.2147/cmar.s276799
Pubmed ID
Authors

Yunke Huang, Jing Xu, Ke Li, Jing Wang, Yilin Dai, Yu Kang

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2021.
All research outputs
#15,432,504
of 17,457,801 outputs
Outputs from Cancer Management and Research
#877
of 1,354 outputs
Outputs of similar age
#159,108
of 195,000 outputs
Outputs of similar age from Cancer Management and Research
#4
of 4 outputs
Altmetric has tracked 17,457,801 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,354 research outputs from this source. They receive a mean Attention Score of 2.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,000 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.